Trial Profile
A phase 1 study to assess three different doses of PH-10 in patients with plaque psoriasis.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 12 Dec 2014
Price :
$35
*
At a glance
- Drugs Rose bengal sodium (Primary)
- Indications Plaque psoriasis
- Focus Adverse reactions
- Sponsors Provectus Biopharmaceuticals
- 12 Dec 2014 New trial record
- 11 Dec 2014 Results published in website of Provectus Biopharmaceuticals, Inc.